These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 34696782)

  • 1. Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA.
    Mao S; Zhang W; Yang F; Guo Y; Wang H; Wu Y; Wang R; Maskey N; Zheng Z; Li C; Ma W; Zhang J; Yan Y; Yao X
    J Exp Clin Cancer Res; 2021 Oct; 40(1):336. PubMed ID: 34696782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EIF4A3-induced circ_0084615 contributes to the progression of colorectal cancer via miR-599/ONECUT2 pathway.
    Jiang Z; Tai Q; Xie X; Hou Z; Liu W; Yu Z; Liang Z; Chen S
    J Exp Clin Cancer Res; 2021 Jul; 40(1):227. PubMed ID: 34253241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.
    Sui X; Wang Y; Liu H
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EIF4A3-Bound hsa_circ_0006847 Exerts a Tumor-Suppressive Role in Gastric Cancer.
    Cao C; Wu X; Li Z; Xie Y; Xu S; Guo J; Sun W
    DNA Cell Biol; 2024 May; 43(5):232-244. PubMed ID: 38513058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0030042 regulates abnormal autophagy and protects atherosclerotic plaque stability by targeting eIF4A3.
    Yu F; Zhang Y; Wang Z; Gong W; Zhang C
    Theranostics; 2021; 11(11):5404-5417. PubMed ID: 33859754
    [No Abstract]   [Full Text] [Related]  

  • 6. EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression.
    Yang M; Hu H; Wu S; Ding J; Yin B; Huang B; Li F; Guo X; Han L
    J Exp Clin Cancer Res; 2022 May; 41(1):165. PubMed ID: 35513835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3.
    Yuan LX; Luo M; Liu RY; Wang HX; Ju LL; Wang F; Cao YL; Wang ZC; Chen L
    BMC Cancer; 2024 Feb; 24(1):239. PubMed ID: 38383334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circ-SIRT1 Promotes Colorectal Cancer Proliferation and EMT by Recruiting and Binding to eIF4A3.
    Wang X; Liu S; Xu B; Liu Y; Kong P; Li C; Li B
    Anal Cell Pathol (Amst); 2021; 2021():5739769. PubMed ID: 34660182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0004872 mitigates proliferation, metastasis and immune escape of meningioma cells by suppressing PD-L1.
    Chen K; Huang Z; Liu C; Ouyang Q; Yan Q; Zheng W; Huang Y
    Metab Brain Dis; 2024 Jun; 39(5):895-907. PubMed ID: 38771413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_circ_0030586 promotes epithelial-mesenchymal transition in prostate cancer via PI3K-AKT signaling.
    Luo GC; Chen L; Fang J; Yan ZJ
    Bioengineered; 2021 Dec; 12(2):11089-11107. PubMed ID: 34852706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EIF4A3-regulated hsa_circ_0001445 can inhibit the progression of laryngeal squamous cell carcinoma via hsa-miR-432-5p-dependent up-regulation of RGMA expression.
    Yu M; Cao H; Yang J; Liu T; Gao J; Wang B
    Cell Cycle; 2023 Sep; 22(18):2038-2056. PubMed ID: 37902305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p.
    Yu YZ; Lv DJ; Wang C; Song XL; Xie T; Wang T; Li ZM; Guo JD; Fu DJ; Li KJ; Wu DL; Chan FL; Feng NH; Chen ZS; Zhao SC
    Mol Cancer; 2022 Jan; 21(1):12. PubMed ID: 34986849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression.
    Li L; Liu D; Chen T; Wei C; Qiao Y; Liu W; Liang Y; Liang Z; Chen C; Li D; Wu B; Zhao X; Huang D; Wu D
    J Exp Clin Cancer Res; 2024 Jul; 43(1):200. PubMed ID: 39030638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EIF4A3-mediated hsa_circ_0088088 promotes the carcinogenesis of breast cancer by sponging miR-135-5p.
    Liu Q; Dong H
    J Biochem Mol Toxicol; 2021 Nov; 35(11):e22909. PubMed ID: 34463003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_cse1l Inhibits Colorectal Cancer Proliferation by Binding to eIF4A3.
    Xu B; Yang N; Liu Y; Kong P; Han M; Li B
    Med Sci Monit; 2020 Aug; 26():e923876. PubMed ID: 32857753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_Circ_0001206 is downregulated and inhibits cell proliferation, migration and invasion in prostate cancer.
    Song Z; Zhuo Z; Ma Z; Hou C; Chen G; Xu G
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2449-2464. PubMed ID: 31198063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0005615 enhances multiple myeloma progression through interaction with EIF4A3 to regulate MAP3K4 m6A modification mediated by ALKBH5.
    Zhu K; Gou F; Zhao Z; Xu K; Song J; Jiang H; Zhang F; Yang Y; Li J
    Leuk Res; 2024 Jun; 141():107451. PubMed ID: 38663164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_0009092/miR-665/NLK signaling axis suppresses colorectal cancer progression via recruiting TAMs in the tumor microenvironment.
    Song J; Liu Q; Han L; Song T; Huang S; Zhang X; He Q; Liang C; Zhu S; Xiong B
    J Exp Clin Cancer Res; 2023 Nov; 42(1):319. PubMed ID: 38008713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA profiles and the potential involvement of down-expression of hsa_circ_0001360 in cutaneous squamous cell carcinogenesis.
    Chen P; Li C; Huang H; Liang L; Zhang J; Li Q; Wang Q; Zhang S; Zeng K; Zhang X; Liang J
    FEBS Open Bio; 2021 Apr; 11(4):1209-1222. PubMed ID: 33569895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.